Ultralife Corporation
ULBI
$7.79
$0.141.77%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.42M | -1.22M | 879.00K | 1.87M | 194.00K |
| Total Depreciation and Amortization | 1.31M | 1.42M | 1.42M | 1.36M | 1.18M |
| Total Amortization of Deferred Charges | 66.00K | 66.00K | 68.00K | 65.00K | 47.00K |
| Total Other Non-Cash Items | 9.72M | -276.00K | 491.00K | 585.00K | 346.00K |
| Change in Net Operating Assets | -2.18M | 209.00K | 3.08M | -502.00K | 1.28M |
| Cash from Operations | 1.49M | 198.00K | 5.94M | 3.37M | 3.05M |
| Capital Expenditure | -882.00K | -995.00K | -1.10M | -895.00K | -606.00K |
| Sale of Property, Plant, and Equipment | -4.00K | 4.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -48.02M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -886.00K | -991.00K | -1.10M | -895.00K | -48.63M |
| Total Debt Issued | -- | -- | -- | -- | 55.00M |
| Total Debt Repaid | -687.00K | -688.00K | -2.69M | -687.00K | -8.04M |
| Issuance of Common Stock | 0.00 | 37.00K | 61.00K | -- | 39.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -24.00K | -- | -1.32M |
| Cash from Financing | -687.00K | -651.00K | -2.65M | -687.00K | 45.68M |
| Foreign Exchange rate Adjustments | 169.00K | -237.00K | 38.00K | 79.00K | -18.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.00K | -1.68M | 2.22M | 1.87M | 80.00K |